FDA Urges Caution On Surgical Robots For Off-Label Women’s Cancer Treatments
Executive Summary
US FDA put out a special alert Feb. 28 underscoring that robotically-assisted surgical devices have not been approved for use in cancer treatment surgery such as mastectomies. The notice urges physicians and patients to carefully weigh the risks and alternatives before performing such procedures.
You may also be interested in...
Study Shows Rapid Adoption Of Robotic Assistance For Unproven Procedures
The authors of a large cohort study of the uptake of robotic-assisted surgery in Michigan hospitals argue that the rapid adoption of robotic techniques is not supported by existing clinical evidence.
Public Interest Groups Will Leverage ‘Bleeding Edge’ Lessons To Push For Device Safety Changes
Public health organizations including the Facebook group ASHES/E-Sisters, and the National Center for Health Research, are pushing for wider distribution of and a big impact from the "The Bleeding Edge" Netflix documentary. They tell Medtech Insight that they will continued to lobby Congress and US FDA to put more safety regulations and protocols into place for devices.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.